These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28957562)

  • 1. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
    Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
    Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies.
    Sonesson SE; Ambrosi A; Wahren-Herlenius M
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):87-95. PubMed ID: 30620419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.
    Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance.
    Bergman G; Eliasson H; Bremme K; Wahren-Herlenius M; Sonesson SE
    Ultrasound Obstet Gynecol; 2009 Nov; 34(5):543-9. PubMed ID: 19795521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
    Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
    Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti-Ro/SSA-antibody-positive pregnancies.
    Cuneo BF; Bitant S; Strasburger JF; Kaizer AM; Wakai RT
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):625-633. PubMed ID: 30784137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
    Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
    Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
    Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
    Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.
    Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y
    Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
    Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
    Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Polynomial Reference Ranges for Atrioventricular Intervals Assessed by Fetal Echocardiography in Anti-Ro/SSA Antibody-Positive Pregnancies to Exclude Fetal Heart Blocks: A Pilot Study.
    Mosimann B; Amylidi-Mohr S; Surbek D; Förger F; Raio L
    Fetal Diagn Ther; 2023; 50(6):422-429. PubMed ID: 37497922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern.
    Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Skog A; Dzikaite V; Bergman G; Fernlund E; Tingström J; Theander E; Rydberg A; Skogh T; Öhman A; Lundström U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Källberg H; Olsson T; Gadler F; Jonzon A; Kockum I; Sonesson SE; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):334-40. PubMed ID: 21953338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro/SSA antibody-mediated cardiac disease.
    Cuneo BF; Fruitman D; Benson DW; Ngan BY; Liske MR; Wahren-Herlineus M; Ho SY; Jaeggi E
    Am J Cardiol; 2011 Mar; 107(5):761-6. PubMed ID: 21247531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.
    Hoxha A; Ruffatti A; Ambrosi A; Ottosson V; Hedlund M; Ottosson L; Anandapadamanaban M; Sunnerhagen M; Sonesson SE; Wahren-Herlenius M
    Clin Exp Immunol; 2016 Dec; 186(3):284-291. PubMed ID: 27548532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies.
    Cuneo BF; Sonesson SE; Levasseur S; Moon-Grady AJ; Krishnan A; Donofrio MT; Raboisson MJ; Hornberger LK; Van Eerden P; Sinkovskaya E; Abuhamad A; Arya B; Szwast A; Gardiner H; Jacobs K; Freire G; Howley L; Lam A; Kaizer AM; Benson DW; Jaeggi E
    J Am Coll Cardiol; 2018 Oct; 72(16):1940-1951. PubMed ID: 30309472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies.
    Gardiner HM; Belmar C; Pasquini L; Seale A; Thomas M; Dennes W; Taylor MJ; Kulinskaya E; Wimalasundera R
    Heart; 2007 Nov; 93(11):1454-60. PubMed ID: 17085531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.
    Buyon JP; Masson M; Izmirly CG; Phoon C; Acherman R; Sinkovskaya E; Abuhamad A; Makhoul M; Satou G; Hogan W; Pinto N; Moon-Grady A; Howley L; Donofrio M; Krishnan A; Ahmadzia H; Levasseur S; Paul E; Owens S; Cumbermack K; Matta J; Joffe G; Lindblade C; Haxel C; Kohari K; Copel J; Strainic J; Doan T; Bermudez-Wagner K; Holloman C; Sheth SS; Killen S; Tacy T; Kaplinski M; Hornberger L; Carlucci PM; Izmirly P; Fraser N; Clancy RM; Cuneo BF
    Arthritis Rheumatol; 2024 Mar; 76(3):411-420. PubMed ID: 37947364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.